John Stagg
Impact in
- Physiology top 0.01%
- Adenosine and Purinergic Signaling
- Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Physiology 56
- Adenosine and Purinergic Signaling 56
- Oncology 55
- Cancer Immunotherapy and Biomarkers 31
- Peptidase Inhibition and Analysis 21
- CAR-T cell therapy research 12
- Co-authors
- Mark J. Smyth (21 shared papers)Bertrand Allard (36 shared papers)Sandra Pommey (23 shared papers)Phillip K. Darcy (10 shared papers)Jacques Galipeau (8 shared papers)Paul A. Beavis (9 shared papers)David Allard (20 shared papers)Upulie Divisekera (5 shared papers)
In The Last Decade
John Stagg
112 papers receiving 11.5k citations
John Stagg's Hit Papers
Peers
Comparison fields: 5 of 128
- Physiology 4.1k
- Immunology 4.1k
- Oncology 4.5k
- Genetics 1.3k
- Biological Psychiatry 159
Countries citing papers authored by John Stagg
This map shows the geographic impact of John Stagg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Stagg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Stagg more than expected).
Fields of papers citing papers by John Stagg
This network shows the impact of papers produced by John Stagg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Stagg. The network helps show where John Stagg may publish in the future.
Co-authors
The 25 scholars most cited alongside John Stagg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy Hit paper breakdown → | 2020 | 978 |
| 2 | The ectonucleotidases Hit paper breakdown → | 2017 | 711 |
| 3 | Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis Hit paper breakdown → | 2010 | 493 |
| 4 | 2010 | 486 | |
| 5 | 2005 | 473 | |
| 6 | 2011 | 400 | |
| 7 | CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer Hit paper breakdown → | 2013 | 399 |
| 8 | The adenosine pathway in immuno-oncology Hit paper breakdown → | 2020 | 391 |
| 9 | Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs Hit paper breakdown → | 2013 | 383 |
| 10 | 2011 | 333 | |
| 11 | 2013 | 301 | |
| 12 | 2012 | 297 | |
| 13 | 2015 | 276 | |
| 14 | 2017 | 269 | |
| 15 | 2014 | 261 | |
| 16 | 2005 | 257 | |
| 17 | 2016 | 235 | |
| 18 | 2015 | 215 | |
| 19 | 2014 | 214 | |
| 20 | 2007 | 193 |
About John Stagg
John Stagg is a scholar working on Physiology, Oncology, Immunology, Biomedical Engineering and Molecular Biology, having authored 114 papers that have together received 11.6k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (56 papers), Cancer Immunotherapy and Biomarkers (31 papers), Immune Cell Function and Interaction (22 papers), Peptidase Inhibition and Analysis (21 papers), Immunotherapy and Immune Responses (19 papers), CAR-T cell therapy research (12 papers), Nanoplatforms for cancer theranostics (12 papers) and Mesenchymal stem cell research (9 papers). The work is most often cited by research in Physiology (4.1k citations), Immunology (4.1k citations), Oncology (4.5k citations), Genetics (1.3k citations) and Biological Psychiatry (159 citations). John Stagg has collaborated with scholars based in Canada, Australia and Belgium. Frequent co-authors include Mark J. Smyth, Bertrand Allard, Sandra Pommey, Phillip K. Darcy, Jacques Galipeau, Paul A. Beavis, David Allard, Upulie Divisekera, Sherene Loi and Simon C. Robson. Their work appears in journals such as Cancer Research, OncoImmunology, Proceedings of the National Academy of Sciences, Oncogene and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.